▶ 調査レポート

世界の胃がん治療市場（2023～2030）：治療法別（化学療法、免疫療法、放射線療法・手術）、疾患別（胃がん/胃食道接合部がん、消化管間質腫瘍）、薬剤クラス別、投与経路別、流通チャネル別
• 英文タイトル：Stomach Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy & Surgery), Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), Drug Class, Route of Administration, Distribution Channel - Global Forecast 2023-2030

360iResearchが調査・発行した産業分析レポートです。世界の胃がん治療市場（2023～2030）：治療法別（化学療法、免疫療法、放射線療法・手術）、疾患別（胃がん/胃食道接合部がん、消化管間質腫瘍）、薬剤クラス別、投与経路別、流通チャネル別 / Stomach Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy & Surgery), Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), Drug Class, Route of Administration, Distribution Channel - Global Forecast 2023-2030 / MRC2311A0162資料のイメージです。• レポートコード：MRC2311A0162
• 出版社/出版日：360iResearch / 2023年10月25日
• レポート形態：英文、PDF、184ページ
• 納品方法：Eメール（受注後2-3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User（1名利用、印刷不可、1年間閲覧）￥592,350 (USD3,949)▷ お問い合わせ
  Site License（同一拠点内共有可、印刷可）￥1,042,350 (USD6,949)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
胃がん治療市場規模は、2022年に46.7億米ドルと推定され、2023年には50.9億米ドルに達すると予測され、CAGR 9.46%で2030年には96.3億米ドルに達すると予測されます。
市場細分化とカバー範囲：
この調査レポートは、胃がん治療市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。
● 治療法別では、化学療法、免疫療法、放射線療法と手術、標的療法について調査しています。予測期間中は、放射線療法と外科手術が大きな市場シェアを占めると予測されます。
● 適応症別では、胃がん／胃食道接合部がん、消化管間質腫瘍が調査対象です。胃がん/胃食道接合部がんは予測期間中に大きな市場シェアを獲得する見込みです。
● 薬剤クラス別では、HER2 拮抗薬、PD-1/PD-L1 阻害薬、VEGFR2 拮抗薬が調査対象です。HER2拮抗薬は予測期間中に大きな市場シェアを獲得する見込みです。
● 投与経路別では、注射剤と経口剤の市場を調査しています。予測期間中、経口剤が大きなシェアを占めると予測されています。
● 流通チャネル別では、病院薬局と専門・小売薬局の市場を調査しています。病院薬局は予測期間中に大きな市場シェアを獲得すると予測されています。
● 地域別では、南北アメリカ、アジア太平洋、ヨーロッパ、中東、アフリカで調査を行いました。詳しい内訳は、南北アメリカはアルゼンチン、ブラジル、カナダ、メキシコ、アメリカを対象に、アメリカはさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスを対象に調査を行いました。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでした。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としています。2022年の市場シェアは南北アメリカが38.75%で最大、次いでヨーロッパ、中東・アフリカでした。

市場統計：
本レポートでは、主要7通貨（米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を提供しています。本レポートでは、2018年から2021年を過去年、2022年を基準年、2023年を推定年、2024年から2030年を予測期間としています。

FPNVポジショニングマトリックス：
FPNVポジショニングマトリックスは、胃がん治療市場を評価するための不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析：
市場シェア分析では、胃がん治療市場のベンダーランドスケープに関する貴重な洞察を提供します。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を提供します。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。

主要企業のプロフィール：
本レポートでは、胃がん治療市場における最近の重要な動向を掘り下げ、主要ベンダーとその革新的なプロフィールを紹介しています。これには、AstraZeneca PLC, Bayer AG, Bristol Myers Squibb Company, Celltrion Healthcare Co., Ltd., Eli Lilly and Company, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Imugene Limited, Jiangsu Hengrui Medicine Co., Ltd., Merck KGaA, Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., and Samsung Bioepis Co., Ltd.などが含まれます。

本レポートでは、以下の点について貴重な洞察を提供しています：
1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を提供します。
2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。
3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を記載しています。
4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価しています。
5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を行いました。

本レポートは、以下のような主要な質問に対応しています：
1. 胃がん治療市場の市場規模および予測はどのようになっていますか？
2. 胃がん治療市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどこですか？
3. 胃がん治療市場の機会を特定するための競争戦略窓口はどのようになっていますか？
4. 胃がん治療市場における最新の技術動向と規制の枠組みはどのようになっていますか？
5. 胃がん治療市場における主要ベンダーの市場シェアはどのようになっていますか？
6. 胃がん治療市場への参入に適したモードと戦略的動きはどのようになっていますか？

1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 胃がん治療の市場分析：治療法別
7. 胃がん治療の市場分析：疾患別
8. 胃がん治療の市場分析：薬剤クラス別
9. 胃がん治療の市場分析：投与経路別
10. 胃がん治療の市場分析：流通チャネル別
11. 南北アメリカの胃がん治療市場
12. アジア太平洋の胃がん治療市場
13. ヨーロッパ・中東・アフリカの胃がん治療市場
14. 競争状況
15. 競争ポートフォリオ
16. 付録

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Stomach Cancer Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population with a high risk for the development of stomach cancer
5.1.1.2. Increasing cases of diabetic and obese patients coupled with sedentary & unhealthy lifestyle
5.1.1.3. Growing emphasis on early screening and detection
5.1.2. Restraints
5.1.2.1. Dearth of gastroenterologists professionals and limited availability of scanning & treatment for timely diagnosis
5.1.3. Opportunities
5.1.3.1. Continuous technological advancements in treatments and diagnostic methods for stomach cancer
5.1.4. Challenges
5.1.4.1. Side effects related to treatments
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Stomach Cancer Treatment Market, by Treatment
6.1. Introduction
6.2. Chemotherapy
6.3. Immunotherapy
6.4. Radiation Therapy & Surgery
6.5. Targeted Therapy
7. Stomach Cancer Treatment Market, by Disease Indication
7.1. Introduction
7.2. Gastric Cancer/Gastroesophageal Junction Cancer
7.3. Gastrointestinal Stromal Tumors
8. Stomach Cancer Treatment Market, by Drug Class
8.1. Introduction
8.2. HER2 Antagonists
8.3. PD-1/PD-L1 Inhibitors
8.4. VEGFR2 Antagonists
9. Stomach Cancer Treatment Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
10. Stomach Cancer Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Specialty & Retail Pharmacies
11. Americas Stomach Cancer Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Stomach Cancer Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Stomach Cancer Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. AstraZeneca PLC
15.1.2. Bayer AG
15.1.3. Bristol Myers Squibb Company
15.1.4. Celltrion Healthcare Co., Ltd.
15.1.5. Eli Lilly and Company
15.1.6. F. Hoffmann La Roche Ltd.
15.1.7. GlaxoSmithKline PLC
15.1.8. Imugene Limited
15.1.9. Jiangsu Hengrui Medicine Co., Ltd.
15.1.10. Merck KGaA
15.1.11. Novartis AG
15.1.12. Otsuka Pharmaceutical Co., Ltd.
15.1.13. Pfizer, Inc.
15.1.14. Samsung Bioepis Co., Ltd.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

TABLE 1. STOMACH CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. STOMACH CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL STOMACH CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. STOMACH CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. STOMACH CANCER TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. STOMACH CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY & SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. STOMACH CANCER TREATMENT MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 11. STOMACH CANCER TREATMENT MARKET SIZE, BY GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. STOMACH CANCER TREATMENT MARKET SIZE, BY GASTROINTESTINAL STROMAL TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 14. STOMACH CANCER TREATMENT MARKET SIZE, BY HER2 ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. STOMACH CANCER TREATMENT MARKET SIZE, BY PD-1/PD-L1 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. STOMACH CANCER TREATMENT MARKET SIZE, BY VEGFR2 ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 18. STOMACH CANCER TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. STOMACH CANCER TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. STOMACH CANCER TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. STOMACH CANCER TREATMENT MARKET SIZE, BY SPECIALTY & RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES STOMACH CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CHINA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. CHINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. CHINA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. INDIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. INDIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. INDIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. JAPAN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. JAPAN STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. JAPAN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. THAILAND STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. THAILAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 114. THAILAND STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 127. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 128. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 145. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 150. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 160. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. NORWAY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. NORWAY STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 175. NORWAY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. POLAND STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. POLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. POLAND STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 185. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 205. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 220. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM STOMACH CANCER TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. STOMACH CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 233. STOMACH CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 234. STOMACH CANCER TREATMENT MARKET LICENSE & PRICING

以下、関連資料のご紹介